Explore 4-Ethoxy-3,5-dimethoxyamphetamine

PiHKAL book II entry 3C-E

ChemSpider 21106237
PubChem 44350137
Wikidata Q4636226
Wikipedia 3C-E
Blotter 3C-E
PsychonautWiki 3C-E
Project Response 3C-E (1438-16)
bluelight.org The Small & Handy 3C-E Thread

Shulgin Index See #117 TMA · Table 5Page 351Row 1

PiHKAL #72 E

Phenethylamine: Von der Strucktur zur Funktion 3C-E: 8.4 (140) 736, 737 · 8.4 741

Thakur, M; Thakur, A; Khadikar, PV. QSAR studies on psychotomimetic phenylalkylamines. Bioorg. Med. Chem., 15 Feb 2004, 12 (4), 825–831. 323 kB. https://doi.org/10.1016/j.bmc.2003.10.027 #22

EMCDDA. New drugs in Europe, 2013, European Monitoring Centre for Drugs and Drug Addiction, Lisbon, 1 Jul 2014. 311 kB.

Zhang, S; Fan, Y; Shi, Z; Cheng, S. DFT-based QSAR and action mechanism of phenylalkylamine and tryptamine hallucinogens. Chin. J. Chem., 1 Apr 2011, 29 (4), 623–630. 166 kB. https://doi.org/10.1002/cjoc.201190132 #16

King, LA. New phenethylamines in Europe. Drug Test. Anal., 1 Jul 2014, 6 (7-8), 808-818. 472 kB. https://doi.org/10.1002/dta.1570

Shulgin, AT. Basic Pharmacology and Effects. In Hallucinogens. A Forensic Drug Handbook; Laing, R; Siegel, JA, Eds., Academic Press, London, 24 Apr 2003; pp 67–137. 6.3 MB.

Nichols, DE. Medicinal chemistry and structure-activity relationships. In Amphetamine and its Analogs; Cho, AK; Segal, DS, Eds., Academic Press, San Diego, CA, 1 Jan 1994; pp 3–41. 8.1 MB.

Braun, U; Braun, G; Jacob, P; Nichols, DE; Shulgin, AT. Mescaline Analogs: Substitutions at the 4-Position. In QuaSAR: Quantitative Structure Activity Relationships of Analgesics, Narcotic Antagonists, and Hallucinogens. NIDA Research Monograph 22; Barnett, G; Trsic, M; Willette, RE, Eds., U.S. Department of Health and Human Services, National Institute of Health, U.S. Government Printing Office, Washington, DC, 1 Jan 1978; pp 27–37. 497 kB. Rhodium.

Chapman, SJ. Novel Psychoactive Spectra: NMR of (mostly) Novel Psychoactive Substances. BLOTTER, 25 Jun 2018, 3 (2). https://doi.org/10.16889/isomerdesign-6 #3C-E NMR

Halberstadt, AL; Chatha, M; Chapman, SJ; Brandt, SD. Comparison of the behavioral effects of mescaline analogs using the head twitch response in mice. J. Psychopharmacol., 1 Mar 2019, 33 (3), 406-414. 901 kB. https://doi.org/10.1177/0269881119826610 #3C-E

Sasaki, R; Kato, M; Matsumoto, T; Udagawa, A; Matsuzaki, R. Analytical data of designer drugs of synthetic phenethylamines. JCCL, 1 Dec 2015, (55), 43–63. 637 kB. #8 Japanese, English abstract MS,NMR,IR,UV

Halberstadt, AL; Chatha, M; Klein, AK; Wallach, J; Brandt, SD. Correlation between the potency of hallucinogens in the mouse head-twitch response assay and their behavioral and subjective effects in other species. Neuropharmacology, 1 May 2020, 167, 107933. 2.4 MB. https://doi.org/10.1016/j.neuropharm.2019.107933 #3C-E

Kolaczynska, KE; Luethi, D; Trachsel, D; Hoener, MC; Liechti, ME. Receptor interaction profiles of 4-alkoxy-3,5-dimethoxy-phenethylamines (mescaline derivatives) and related amphetamines. Front. Pharmacol., 9 Feb 2022, 12 794254. 1.0 MB. https://doi.org/10.3389/fphar.2021.794254 #21

Benington, F; Morin, RD; Clarke, LC. Synthesis of 4-hydroxy- and 4-ethoxy-3,5-dimethoxy-β-phenethylamines. J. Am. Chem. Soc., 1 Nov 1954, 76 (21), 5555–5556. 307 kB. https://doi.org/10.1021/ja01650a084 #III

Clare, BW. The frontier orbital phase angles: Novel QSAR descriptors for benzene derivatives, applied to phenylalkylamine hallucinogens. J. Med. Chem., 24 Sep 1998, 41 (20), 3845–3856. 239 kB. https://doi.org/10.1021/jm980144c #87

AEM · α-Ethylmescaline

3,4-Diethoxy-5-methoxyphenethylamine · ASB · Asymbescaline

2C-O-4 · 4-Isopropoxy-2,5-dimethoxyphenethylamine

2-Ethoxy-4,5-dimethoxyamphetamine · EMM

IP · Isoproscaline

2,5-Dimethoxy-4-ethoxyamphetamine · MEM

2,4-Dimethoxy-5-ethoxyamphetamine · MME

MP · Metaproscaline

P · Proscaline

SB · Symbescaline

N-HO-4C-D · HOT-ARIADNE · α-Ethyl-4-methyl-2,5-dimethoxyphenethylamine

4C-TMPEA-6 · α-Ethyl-2,4,6-trimethoxyphenethylamine

BOED · β-Ethoxy-2,5-dimethoxy-4-methylphenethylamine

2,3,6-Trimethoxy-4-methylamphetamine · Z-7.2

N,N-Dimethyl-3,4,5-trimethoxyphenethylamine · N,N-Dimethylmescaline

N-Me-TMA · METHYL-TMA

N-Me-TMA-2 · METHYL-TMA-2

N-Me-TMA-6 · METHYL-TMA-6

2,5-Dimethoxy-4-propoxyphenethylamine · 2C-O-7

N-tert-Butyl-β,4-dihydroxy-3-(hydroxymethyl)phenethylamine · Salbutamol

homo-TMA-2

homo-TMA-3

homo-TMA-6

N,N-Me-β,3,4-TMPEA · β,3,4-Trimethoxy-N,N-dimethylphenethylamine

β-HO-β,N,N-Me-2,5-DMPEA · β-Hydroxy-β,N,N-trimethyl-2,5-dimethoxyphenethylamine

β-HO-N,N-Me-2,5-DMA · β-Hydroxy-N,N-dimethyl-2,5-dimethoxyamphetamine

β-HO-N-Me-2,5-DEPEA · β-Hydroxy-N-methyl-2,5-diethoxyphenethylamine

β-HO-2,5-DEA · β-Hydroxy-2,5-diethoxyamphetamine

2,3,4-Trimethoxymethamphetamine · N-Me-TMA-3

4C-TMPEA-3 · α-Ethyl-2,3,4-trimethoxyphenethylamine

4C-HM · α-Ethyl-4-hydroxymethyl-2,5-dimethoxyphenethylamine

BOE · β-Methoxy-4-ethyl-2,5-dimethoxyphenethylamine

4-(2-Hydroxyethyl)-2,5-dimethoxyamphetamine · DOEH

4C-MeO · 4C-O · 4C-TMA-2

N-Isopropyl-4-hydroxy-3,5-dimethoxyphenethylamine · DESMETHYL-iPr

α,α-Dimethyl-3,4,5-trimethoxyphenethylamine · α-MM-M

4-Ethoxy-2,6-dimethoxyamphetamine · ψ-MEM

4-Methoxymethyl-2,5-dimethoxyamphetamine · DOMOM

β,β-Dimethyl-3,4,5-trimethoxyphenethylamine · β,β-Dimethylmescaline

MIP · Metaisoproscaline

2-Et-M · 2-Ethyl-3,4,5-trimethoxyphenethylamine · 2-Ethylmescaline

3,4,5-Trimethoxy-2,6-dimethylphenethylamine · DMe-M · Dimethylmescaline

2,4,5-Trimethoxy-3,6-dimethylphenethylamine · DMe-2C-O

2C-EOM · 4-Ethoxymethoxy-2,5-dimethoxyphenethylamine

6941

6939

3,4-Dimethoxy-5-methoxymethylamphetamine · 3-homo-TMA

4C-TMPEA-5

p2-222: 3C-E